Quotient Limited Announces CE Mark Approval for Initial Serological Disease Screening Microarray - Nasdaq

--Quotient Limited, a commercial-stage diagnostics company, headquartered in Eysins, Switzerland, today announced that it has received the Conformité Européene Mark approval for the Initial ... Read More

Quotient Limited Announces the Submission of the Initial SDS Microarray CE mark Filing for MosaiQ™ - Markets Insider

JERSEY, Channel Islands, July 01, 2019 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland, today ... Read More

Quotient Limited: MosaiQ's Approval And Launch A Few Months Away

Quotient's MosaiQ is just a few months away from receiving EU approval - the last step is the CE mark for the initial MosaiQ IH microarray. The company is on its way to significantly expand MosaiQ ... Read More

Quotient Limited Announces Receipt of the ISO 13485:2016 Certification of its State of the Art MosaiQ™ Microarray Manufacturing Facility - Markets Insider

JERSEY, Channel Islands, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today reported receipt of the formal ISO 13485:2016 ... Read More

Quotient Limited reports the submission of the initial IH CE mark filing and the successful completion of the key regulatory audits of its new BioCampus facility - Stockhouse

Initial IH CE mark submission has been completed and filed on schedule Successful facility audits pave the way for an on time BioCampus ramp up JERSEY, Channel Islands, Sept. 25, 2018 (GLOBE NEWSWIRE) ... Read More

Quotient Limited Announces CE Mark For Its Sars-Cov-2 (Covid-19) Antibody Microarray | Reuters

* QUOTIENT LTD - MOSAIQ COVID-19 ANTIBODY MICROARRAY IS DESIGNED AS A SEROLOGICAL DISEASE SCREEN SPECIFIC TO COVID-19 Source text for Eikon: Further company coverage: Sign up here. Our Standards ... Read More

2021-10-01 | Quotient Limited Provides Update on CE Marking Progress of the MosaiQ(TM) Expanded Immunohematology Microarray | Press Release - Stockhouse

JERSEY, Channel Islands, Oct. 01, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced the launch of the review process of the ... Read More

Quotient Limited Announces the Submission of the Initial SDS Microarray CE mark Filing for MosaiQ™ - CNN Business

Quotient Limited Announces the Submission of the Initial SDS Microarray CE mark Filing for ... of its initial Serological Disease Screening (SDS) Microarray for use with its CE marked MosaiQ ... Read More